Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07343349
Recruiting
Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions
Not applicable · Denmark · 3 sites
Registry update: 21 Jan 2026
NCT07373639
Recruiting
A Long-term Follow-up Study in Patients Who Received BEAM-101
Not applicable · United States · 17 sites
Registry update: 28 Jan 2026
NCT07444307
Recruiting
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Phase 1 · China · 3 sites
Registry update: 2 Mar 2026
NCT07925996
Recruiting
Dermal Priming in Enhancing Vaccine Immunogenicity
Not applicable · United Kingdom · 1 site
Registry update: 9 Nov 2026
2025-521738-27-00
Recruiting
A Phase II Randomized Clinical Trial Comparing Two Cycles Versus Four Cycles of Combination Therapy with Cetuximab, Avelumab, Cisplatin, and Docetaxel in Patients with Recurrent Metastatic Head and Neck Cancer - AVETUX-HN
Phase 2 · Germany · 5 sites
Registry update: 11 Jun 2026
NCT07275931
Recruiting
Digital Support Program for Patients With Heart Failure - a Cluster-Randomized Hybrid Type 2 Study
Not applicable · Sweden · 1 site
Registry update: 27 Feb 2026
NCT07390214
Recruiting
REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".
Not applicable · Germany · 1 site
Registry update: 5 Feb 2026
NCT07296458
Recruiting
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Phase 3 · China · 2 sites
Registry update: 2 Nov 2026
NCT07306273
Recruiting
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Phase 2 · China · 1 site
Registry update: 29 Dec 2025
NCT07371234
Recruiting
Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 1 Sept 2026
NCT07381790
Recruiting
Modern Technologies in Lower Respiratory Tract Infections in Children
Not applicable · Norway · 2 sites
Registry update: 2 Feb 2026
NCT06818019
Recruiting
Withdrawal of Dupilumab in Severe Asthma
Phase 4 · France · 32 sites
Registry update: 8 Oct 2026
NCT07214584
Recruiting
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
Not applicable · United States · 1 site
Registry update: 12 Feb 2026
NCT06200259
Recruiting
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
Not applicable · United States · 1 site
Registry update: 18 Dec 2025
NCT07306286
Recruiting
Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Phase 2 · China · 1 site
Registry update: 29 Dec 2025
NCT07220525
Recruiting
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT07420634
Recruiting
Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes
Not applicable · India · 1 site
Registry update: 19 Feb 2026
NCT07215494
Recruiting
A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
Not applicable · China · 1 site
Registry update: 16 Sept 2026
NCT07302672
Recruiting
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
Not applicable · China · 1 site
Registry update: 14 Jul 2026
NCT07282600
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · China, Czechia, Germany, Spain, India, Japan, South Korea, Mexico, Poland, Puerto Rico, Slovakia, Taiwan, United States · 143 sites
Registry update: 4 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.